Archive
A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Sarepta to pay $200M milestone to Arrowhead; Enlivex reports osteoarthritis data
Plus, news about Clearside Biomedical, Pfizer, Astellas, Merck, MindImmune Therapeutics and Poxel: 💵 Sarepta to pay Arrowhead $200M as it continues type 1 myotonic dys...
Directory ribbon
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page